Survivorship: Pregnancy Risks and Long-Term Monitoring
At a Glance
Pregnancies after Asherman syndrome are moderate-to-high risk due to potential complications like placenta accreta and restricted fetal growth. Working with a Maternal-Fetal Medicine (MFM) specialist is crucial for advanced ultrasound monitoring and safe delivery planning.
Achieving a pregnancy after Asherman syndrome is a significant milestone, but it also marks the beginning of a new phase of specialized care. Because the uterine lining has been scarred, the way the placenta attaches and the way the uterus supports a growing baby are different than in a typical pregnancy [1][2].
Understanding Pregnancy Risks
Most pregnancies after Asherman syndrome are successful, but they are classified as moderate-to-high risk [3]. This is because the scar tissue can disrupt the healthy development of the decidua (the specialized lining that forms during pregnancy) [2].
Placental Complications
The most significant risk is Placenta Accreta Spectrum (PAS) [2]. This occurs when the placenta attaches too deeply into the uterine wall because the protective lining is thin or missing [1][2].
- PAS can be difficult to see on standard ultrasounds and may not be discovered until delivery [4].
- It increases the risk of postpartum hemorrhage (heavy bleeding after birth), as the placenta may not separate easily from the uterine wall [2][5].
Fetal Growth and Timing
- Intrauterine Growth Restriction (IUGR): Because the scarred lining may not provide the same level of blood flow as a healthy lining, the baby may grow more slowly than expected [2][5].
- Preterm Birth: There is an increased chance of the baby arriving before 37 weeks, often due to placental issues or the need for an early delivery to manage maternal health [2][6].
The Role of the MFM Specialist
Due to these risks, it is crucial to include a Maternal-Fetal Medicine (MFM) specialist—an obstetrician with advanced training in high-risk pregnancies—in your care team [3][5].
- Advanced Imaging: MFMs use high-resolution ultrasounds to monitor placental placement and fetal growth more closely than a standard OBGYN [3].
- Delivery Planning: They help coordinate a safe delivery plan, ensuring that the hospital is prepared for potential complications like heavy bleeding [7][5].
Alternative Paths to Family Building
For some patients, despite expert surgical intervention, the uterine lining (the functionalis layer) remains too thin or damaged to support a pregnancy safely. If your doctor determines that the uterus cannot be restored, it is important to know that gestational surrogacy remains a viable alternative. In surrogacy, a healthy embryo created from your (or a donor’s) egg and sperm is transferred to the uterus of a gestational carrier. While emotionally and financially taxing, this is a proven path to biological parenthood for patients with severe, treatment-resistant Asherman syndrome.
Long-Term Monitoring and Recurrence
If you have completed your family or are not currently trying to conceive, you may wonder if the scar tissue will return.
- Spontaneous Recurrence: Asherman syndrome does not usually “start” on its own; it requires a trigger like trauma or infection [8]. However, if your surgery was recent, there is a risk of adhesion reformation (the scars growing back) during the healing phase [9][10].
- Symptom Tracking: Even if you are not seeking pregnancy, you should monitor for menstrual disturbances or cyclical pelvic pain. These can indicate that adhesions are blocking the flow of a period, which can lead to discomfort or other uterine issues [11][12].
While the journey through Asherman syndrome requires persistence and extra care, understanding these long-term factors allows you to advocate for the specialized monitoring you need for a healthy future [3][13].
Common questions in this guide
What are the pregnancy risks after having Asherman syndrome?
Why do I need a Maternal-Fetal Medicine (MFM) specialist for my pregnancy?
Can Asherman syndrome scar tissue grow back?
What are my options if my uterus cannot carry a pregnancy?
How does my doctor check for placenta accreta during pregnancy?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Since I have a history of Asherman syndrome, can you refer me to a Maternal-Fetal Medicine (MFM) specialist for an early placental assessment?
- 2.How frequently should we monitor my baby's growth to check for signs of intrauterine growth restriction (IUGR)?
- 3.What is your plan for managing potential postpartum hemorrhage during my delivery?
- 4.How often should I have follow-up ultrasounds or hysteroscopies if I am not planning to get pregnant immediately?
- 5.Do you recommend a specialized ultrasound (like a 'placental sweep') in the second trimester to look for placenta accreta?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (13)
- 1
Secondary Prevention of Intrauterine Adhesions Following Hysteroscopic Surgery in Women With Asherman Syndrome: Is Something Better Than Nothing?
Kelley AS, Giuliani E, Schon SB
Clinical obstetrics and gynecology 2020; (63(2)):320-326 doi:10.1097/GRF.0000000000000510.
PMID: 31815774 - 2
Effects of Asherman Syndrome on Maternal and Neonatal Morbidity with Evaluation by Conception Method.
Wang J, Movilla P, Morales B, et al.
Journal of minimally invasive gynecology 2021; (28(7)):1357-1366.e2 doi:10.1016/j.jmig.2020.10.004.
PMID: 33065259 - 3
"The threat of Asherman syndrome": a propensity score-matched study of fetal-maternal outcomes.
Hanstede MMF, Veersema S, Emanuel MH, et al.
Fertility and sterility 2025; (124(5 Pt 2)):1104-1114 doi:10.1016/j.fertnstert.2025.06.027.
PMID: 40578664 - 4
Incidence, risk factors and maternal outcomes of unsuspected placenta accreta spectrum disorders: a retrospective cohort study.
Zhao J, Li Q, Liao E, et al.
BMC pregnancy and childbirth 2024; (24(1)):76 doi:10.1186/s12884-024-06254-z.
PMID: 38262978 - 5
The perinatal outcomes of women treated for Asherman syndrome: a propensity score-matched cohort study.
Mára M, Borčinová M, Lisá Z, et al.
Human reproduction (Oxford, England) 2023; (38(7)):1297-1304 doi:10.1093/humrep/dead092.
PMID: 37196339 - 6
The birth weight in pregnant women with Asherman syndrome compared to normal intrauterine cavity: A case-control study.
Baradwan S, Baradwan A, Bashir M, Al-Jaroudi D
Medicine 2018; (97(32)):e11797 doi:10.1097/MD.0000000000011797.
PMID: 30095642 - 7
Incidence and Clinical Implications of Placenta Accreta Spectrum after Treatment for Asherman Syndrome.
Tavcar J, Movilla P, Carusi DA, et al.
Journal of minimally invasive gynecology 2023; (30(3)):192-198 doi:10.1016/j.jmig.2022.11.013.
PMID: 36442752 - 8
Prevalence and risk factors of intrauterine adhesions in women with a septate uterus: a retrospective cohort study.
Shen M, Duan H, Chang Y, Lin Q
Reproductive biomedicine online 2022; (44(5)):881-887 doi:10.1016/j.rbmo.2022.02.004.
PMID: 35361544 - 9
The predictive value of serum IL-17A and IL-6 expression in postoperative recurrence in patients with intrauterine adhesion.
Cui X, Xiao HC, Pan W
American journal of reproductive immunology (New York, N.Y. : 1989) 2024; (91(1)):e13808 doi:10.1111/aji.13808.
PMID: 38282600 - 10
Extended intrauterine balloon stent use to prevent adhesion reformation after hysteroscopic adhesiolysis: a randomized trial.
Luo Y, Liu Y, Xiao Y, et al.
Fertility and sterility 2025; (124(1)):144-152 doi:10.1016/j.fertnstert.2025.01.024.
PMID: 39884334 - 11
CSF1-associated decrease in endometrial macrophages may contribute to Asherman's syndrome.
Liu D, Wang J, Zhao G, et al.
American journal of reproductive immunology (New York, N.Y. : 1989) 2020; (83(1)):e13191 doi:10.1111/aji.13191.
PMID: 31536655 - 12
Reproductive Outcome of Patients with Asherman's Syndrome: A SAIMS Experience.
Bhandari S, Bhave P, Ganguly I, et al.
Journal of reproduction & infertility 2015; (16(4)):229-35.
PMID: 27110522 - 13
A retrospective cohort study to examine factors affecting live birth after hysteroscopic treatment of intrauterine adhesions.
Zhao Y, Huang X, Huang R, et al.
Fertility and sterility 2024; (121(5)):873-880 doi:10.1016/j.fertnstert.2024.01.022.
PMID: 38246404
This page is for informational purposes only and does not replace professional medical advice. Always consult your obstetrician or Maternal-Fetal Medicine specialist regarding your specific pregnancy risks and care plan.
Get notified when new evidence is published on Asherman syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.